6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline

C132H118F4N30O3 — CID 158770893

IUPAC6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline
SMILESCc1cc(F)cc(CCc2nc(-c3ccc4nc[nH]c(=O)c4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncc(C(N)=O)nc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncncc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccnc4ccc(C(N)=O)cc34)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cccc(CCc2nc(-c3ccc4ncccc4c3)c(-c3ccn(C)n3)[nH]2)c1
InChIInChI=1S/C28H25FN6O.C27H24FN7O.C26H23FN6O.C26H23FN6.C25H23N5/c1-16-12-17(14-19(29)13-16)2-7-25-32-26(27(33-25)24-9-11-35(34-24)20-4-5-20)21-8-10-31-23-6-3-18(28(30)36)15-22(21)23;1-15-10-16(12-18(28)11-15)2-7-24-32-25(26(33-24)21-8-9-35(34-21)19-4-5-19)17-3-6-20-22(13-17)31-23(14-30-20)27(29)36;1-15-10-16(12-18(27)11-15)2-7-23-30-24(17-3-6-21-20(13-17)26(34)29-14-28-21)25(31-23)22-8-9-33(32-22)19-4-5-19;1-16-10-17(12-20(27)11-16)2-7-24-30-25(18-3-6-22-19(13-18)14-28-15-29-22)26(31-24)23-8-9-33(32-23)21-4-5-21;1-17-5-3-6-18(15-17)8-11-23-27-24(25(28-23)22-12-14-30(2)29-22)20-9-10-21-19(16-20)7-4-13-26-21/h3,6,8-15,20H,2,4-5,7H2,1H3,(H2,30,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H2,29,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H,30,31)(H,28,29,34);3,6,8-15,21H,2,4-5,7H2,1H3,(H,30,31);3-7,9-10,12-16H,8,11H2,1-2H3,(H,27,28)
InChIKeyIPVUGCWIWMHATP-UHFFFAOYSA-N
MW2248.59 g/mol
LogP25.02
Rot. Bonds31

About 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline

6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline (PubChem CID 158770893) has the molecular formula C132H118F4N30O3 and a molecular weight of 2248.59 g/mol. Its IUPAC name is 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline.

Molecular Properties

Compound Name6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline
PubChem CID158770893
Molecular FormulaC132H118F4N30O3
Molecular Weight2248.59 g/mol
Exact Mass2246.99
IUPAC Name6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline
SMILESCc1cc(F)cc(CCc2nc(-c3ccc4nc[nH]c(=O)c4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncc(C(N)=O)nc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncncc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccnc4ccc(C(N)=O)cc34)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cccc(CCc2nc(-c3ccc4ncccc4c3)c(-c3ccn(C)n3)[nH]2)c1
InChIInChI=1S/C28H25FN6O.C27H24FN7O.C26H23FN6O.C26H23FN6.C25H23N5/c1-16-12-17(14-19(29)13-16)2-7-25-32-26(27(33-25)24-9-11-35(34-24)20-4-5-20)21-8-10-31-23-6-3-18(28(30)36)15-22(21)23;1-15-10-16(12-18(28)11-15)2-7-24-32-25(26(33-24)21-8-9-35(34-21)19-4-5-19)17-3-6-20-22(13-17)31-23(14-30-20)27(29)36;1-15-10-16(12-18(27)11-15)2-7-23-30-24(17-3-6-21-20(13-17)26(34)29-14-28-21)25(31-23)22-8-9-33(32-22)19-4-5-19;1-16-10-17(12-20(27)11-16)2-7-24-30-25(18-3-6-22-19(13-18)14-28-15-29-22)26(31-24)23-8-9-33(32-23)21-4-5-21;1-17-5-3-6-18(15-17)8-11-23-27-24(25(28-23)22-12-14-30(2)29-22)20-9-10-21-19(16-20)7-4-13-26-21/h3,6,8-15,20H,2,4-5,7H2,1H3,(H2,30,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H2,29,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H,30,31)(H,28,29,34);3,6,8-15,21H,2,4-5,7H2,1H3,(H,30,31);3-7,9-10,12-16H,8,11H2,1-2H3,(H,27,28)
InChIKeyIPVUGCWIWMHATP-UHFFFAOYSA-N
XLogP25.02
TPSA441.77 Ų
H-Bond Donors8
H-Bond Acceptors25
Rotatable Bonds31
Heavy Atoms169
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002248.59
LogP ≤ 525.02
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1025

Analyze 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline?
The IUPAC name of 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline (CID 158770893) is 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline.
What is the SMILES notation for 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline?
The canonical SMILES for 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline is Cc1cc(F)cc(CCc2nc(-c3ccc4nc[nH]c(=O)c4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncc(C(N)=O)nc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncncc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccnc4ccc(C(N)=O)cc34)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cccc(CCc2nc(-c3ccc4ncccc4c3)c(-c3ccn(C)n3)[nH]2)c1.
What is the InChIKey of 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline?
The InChIKey is IPVUGCWIWMHATP-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25FN6O.C27H24FN7O.C26H23FN6O.C26H23FN6.C25H23N5/c1-16-12-17(14-19(29)13-16)2-7-25-32-26(27(33-25)24-9-11-35(34-24)20-4-5-20)21-8-10-31-23-6-3-18(28(30)36)15-22(21)23;1-15-10-16(12-18(28)11-15)2-7-24-32-25(26(33-24)21-8-9-35(34-21)19-4-5-19)17-3-6-20-22(13-17)31-23(14-30-20)27(29)36;1-15-10-16(12-18(27)11-15)2-7-23-30-24(17-3-6-21-20(13-17)26(34)29-14-28-21)25(31-23)22-8-9-33(32-22)19-4-5-19;1-16-10-17(12-20(27)11-16)2-7-24-30-25(18-3-6-22-19(13-18)14-28-15-29-22)26(31-24)23-8-9-33(32-23)21-4-5-21;1-17-5-3-6-18(15-17)8-11-23-27-24(25(28-23)22-12-14-30(2)29-22)20-9-10-21-19(16-20)7-4-13-26-21/h3,6,8-15,20H,2,4-5,7H2,1H3,(H2,30,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H2,29,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H,30,31)(H,28,29,34);3,6,8-15,21H,2,4-5,7H2,1H3,(H,30,31);3-7,9-10,12-16H,8,11H2,1-2H3,(H,27,28).
What are the key properties of 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline?
6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline has a molecular weight of 2248.59 g/mol, XLogP of 25.02, 31 rotatable bonds, 8 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline is sourced from PubChem (CID 158770893), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).